Ryoichi Shiroki

Ryoichi Shiroki

Auto-generated profile, based on publicly available information

Ryoichi Shiroki

Department of Urology Fujita Health University Toyoake Japan

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2018 in International Journal of Urology
Verified
Journal Article
Open access
PDF file
KTKazushi Tanaka
Kazushi Tanaka
JTJun Teishima
Jun Teishima
ATAtsushi Takenaka
Atsushi Takenaka
RSRyoichi Shiroki
Ryoichi Shiroki
YKYasuyuki Kobayashi
Yasuyuki Kobayashi
MFMasato Fujisawa
Masato Fujisawa
Objectives: To evaluate the outcomes of robotic partial nephrectomy compared with those of laparoscopic partial nephrectomy for T1 renal tumors in Japanese centers.Methods: Patients with a T1 renal tumor who underwent robotic partial nephrectomy were eligible for inclusion in the present study. The primary end‐point consisted of three components: a negative surgical margin, no conversion to open or laparoscopic surgery and a warm ischemia time ≤25 min. We compared data from these patients with the data from a retrospective study of laparoscopic partial nephrectomy carried out in Japan.Results: A total of 108 patients were registered in the present study; 105 underwent robotic partial nephrectomy. The proportion of patients who met the primary end‐point was 91.3% (95% confidence interval 84.1–95.9%), which was significantly higher than 23.3% in the historical data. Major complications were seen in 19 patients (18.1%). The mean change in the estimated glomerular filtration rate in the operated kidney, 180 days postoperatively, was −10.8 mL/min/1.73 m2 (95% confidence interval −12.3–9.4%).Conclusions: Robotic partial nephrectomy for patients with a T1 renal tumor is a safe, feasible and more effective operative method compared with laparoscopic partial nephrectomy. It can be anticipated that robotic partial nephrectomy will become more widely used in Japan in the future.

1 March 2021 in Prostate International
Verified
Journal Article
Open access
AYAtsuhiko Yoshizawa
Atsuhiko Yoshizawa
KTKiyoshi Takahara
Kiyoshi Takahara
MSMasanobu Saruta
Masanobu Saruta
KZKenji Zennami
Kenji Zennami
TNTakuhisa Nukaya
Takuhisa Nukaya
RSRyoichi Shiroki
Ryoichi Shiroki
Disease progression in castrate-resistant prostate cancer (PCa) is most commonly driven by the reactivation of androgen receptor (AR) signaling and involves AR splice variants including ARV7. We used the ARV7-positive PCa cell line, 22Rv1, to study the relationship of the PCa marker α-methylacyl-CoA racemase (AMACR), AR, and ARV7 in PCa. Docetaxel addition but not AMACR inhibition decreased the proliferation of 22Rv1 cells. The combination of AMACR inhibition and docetaxel treatment resulted in a maximum reduction of cell proliferation. The Western blotting analysis revealed that both AR and ARV7 expression were significantly decreased with the use of charcoal-stripped serum following AMACR inhibition and docetaxel treatment. AMACR inhibition and docetaxel treatment in the charcoal-stripped serum condition reduced the proliferation of 22Rv1, possibly via the downregulation of the heat shock protein 27. Using cell proliferation and Western blot analysis, we demonstrated that AMACR inhibition and docetaxel treatment, under androgen deprivation conditions, significantly reduced the proliferation of ARV7 positive cancer cells and decreased the levels of AR and ARV7 expression, possibly via downregulation of heat shock protein 27.

1 January 2011 in The Japanese Journal of Urology
Verified
Journal Article
Open access
RSRyoichi Shiroki
Ryoichi Shiroki
TMTakahiro Maruyama
Takahiro Maruyama
MKMamoru Kusaka
Mamoru Kusaka
SWShigeto Washida
Shigeto Washida
MHMasaru Hikichi
Masaru Hikichi
KHKiyotaka Hoshinaga
Kiyotaka Hoshinaga
For the management of patients with small renal tumor, laparoscopic partial nephrectomy (LPN) provides similar oncological control as radical nephrectomy (RN) and is superior to RN with respect to preserving renal function and preventing chronic kidney disease (CKD). The challenge of LPN is to resect a tumor in a bloodless field within a limited warm ischemia time (WIT) , followed by hemostatic renorrhaphy under restricted movement of laparoscopic forceps. Therefore, LPN still remains challenging to even experienced laparoscopic surgeon. DaVinci device improved the movability of forceps in LPN and provided three-dimensional visualization. We evaluated outcome and safety of our first series of robot-assisted laparoscopic partial nephrectomy (RALPN) for localized kidney tumor. There was no previous report of RALPN undertaken in our country. Since August 2010, our team carried out RALPN for a total of five cases of renal tumor. There were four males and one female with an age range of 41 to 65 years-old. Size of tumor ranged from 15 to 28 mm, located in exophytic region, and four cases in right side and one in left. RALPN was undertaken by single surgeon through transperitoneal approach in two cases and retroperitoneal in tree. RALPN was completed in all patients without conversion to open or hand-assisted surgery. The median operative time and the estimated blood loss were 189 minutes, ranged from 150 to 264, and 29 ml, from 10 to 50, respectively. The median volume of removed tumor and the length of WIT were 7 g, ranged from 4 to 13 g, and 18 minutes, from 13 to 26 minutes, respectively. No complications or reoperations were associated during or post our RALPN cases. Pathological examination of removed tumor showed renal cell carcinoma with negative surgical margin in all cases. Introduction of daVinci device to LPN made this procedure, RALPN, a secured and promising one, which leading to shorten the WIT and to achieve satisfied renorrhaphy. Even for the complex and technically challenging renal tumors, robotic assistance is expected to provide patients the benefit of minimally invasive surgery with safety and satisfactory renal function.

1 February 2022 in Asian Journal of Endoscopic Surgery
Verified
Journal Article
Closed access
PDF file
KNKenichi Nakamura
Kenichi Nakamura
SSSusumu Shibasaki
Susumu Shibasaki
KFKosuke Fukaya
Kosuke Fukaya
MNMasaya Nakauchi
Masaya Nakauchi
TTTsuyoshi Tanaka
Tsuyoshi Tanaka
KSKoichi Suda
Koichi Suda

1 February 2022
Verified
Journal Article
Open access
FIFumitaka Ito
Fumitaka Ito
HKHidetoshi Kobayashi
Hidetoshi Kobayashi
MIMASAYUKI ITO
MASAYUKI ITO
RSRyoichi Shiroki
Ryoichi Shiroki
SHShinya Hayashi
Shinya Hayashi
The purpose of this study was to determine the most appropriate seed arrangement by comparing two different methods (linked seeds and loose seeds). A total of sixty-one patients (28 linked seed brachytherapy cases and 33 loose seed brachytherapy cases) with clinically localized prostate cancer were treated with I-125 permanent prostate brachytherapy. Modified peripheral loading was the method used for seed placement. The parameters evaluated were as follows: prostate D90, V100, and V150; urethral D90, D10, and D5; and rectal V100 (RV100) and D2 (RD2). Coefficient parameters (r and r2) were assessed by regression analysis. Prostate V150, urethral D90, urethral D10, urethral D5, and RD2 showed significant correlations between both methods in all patients. Urethral D90, urethral D10, urethral D5, and RD2 showed significant correlations in patients who received linked seed brachytherapy. Prostate V150, urethral D90, urethral D10, urethral D5, RV100, and RD2 showed significant correlations in patients who received loose seed brachytherapy. Urethral D90, urethral D10, urethral D5, and RD2 showed significant correlations in the linked seed and loose seed brachytherapy analyses. In contrast, prostate D90 and prostate V100 showed no correlation. Parameters of normal organ damage showed good correlations between intraplan and postplan parameters. These parameters may be useful to determine normal organ damage during guided brachytherapy with two different methods (linked seeds and loose seeds).

22 September 2016 in European Urology Supplements
Verified
Journal Article
Closed access
RSR. Shiroki
R. Shiroki
NFN. Fukami
N. Fukami
KFK. Fukaya
K. Fukaya
MTM. Takenaka
M. Takenaka
MIMasayuki Itoh
Masayuki Itoh
FNFukami Naohiko
Fukami Naohiko